Treatment with an aromatase inhibitor, either alone or in combination with growth hormone (GH), slowed bone advancement and enhanced adult height in mid-pubertal boys with a short predicted adult ...

Essential Tools for Managing Hormone Receptor-Positive Breast Cancer Presented by Learn Look Locate and Walgreens “We know ...

Aromatase inhibitors (AIs) are becoming the hormonal treatment of choice for postmenopausal women with early breast cancer. Large, well-controlled clinical studies have established the efficacy ...

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for ...

A new drug that reduces the risk of breast cancer recurrence has been approved in England. According to an analysis by the ...

Balancing estrogen isn’t just about cutting soy—it’s about strategic, science-backed foods that go beyond the basics ...

A new twice-daily pill has been approved for NHS use, offering a significant reduction in the risk of certain breast cancers ...

Breast health, including breast cancer early detection and prevention, assessing and managing breast skin changes, and premature breast development ...

The new potential therapy is called a dual aromatase-steroid sulfatase inhibitor (DASI). Some of these new compounds were found to effectively block both enzymes, which may help reduce estrogen ...